AOD-9604 news and clinical trials
Also known as: AOD9604 · AOD 9604 · Advanced Obesity Drug · AOD-9604 acetate · AOD 9064
Updated 43 sources
2 new studies in the last 12 months, newest first: trial registrations and results, PubMed papers, FDA actions and press coverage that name AOD-9604. Each line links to the primary source.
April 2026
- StudyPubMedSafety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance (opens PubMed)
Researchers published a review of approved and unapproved peptide therapies used in sports medicine. They found that while unapproved peptides often show potential for tissue repair in animal models, human safety data remain scarce and carry a risk of serious harm.
Sports medicine (Auckland, N.Z.)ReviewPMID 41966639
January 2026
- StudyPubMedTherapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions (opens PubMed)
A review published in the Journal of the American Academy of Orthopaedic Surgeons analyzed the use of therapeutic peptides in orthopaedics. The authors noted that while peptides show promise in preclinical models for tissue regeneration, there is currently a lack of clinical trials.
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviewsReviewPMID 41490200
Searched as: AOD-9604. Summaries are one or two sentences, published only when every number in them appears in the source record. A tracker, not medical advice.